United Kingdom - English - VMD (Veterinary Medicines Directorate)

norbrook laboratories limited - epinephrine acid tartrate, lidocaine hydrochloride - solution for injection - neurological agent local anaesthetic - horses

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - adrenaline acid tartrate 1:100000; lidocaine hydrochloride 2%;   - solution for injection - 1:100000/2% in 2.2ml - active: adrenaline acid tartrate 1:100000 lidocaine hydrochloride 2%  

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - adrenaline acid tartrate 1:200000; bupivacaine hydrochloride monohydrate 0.375%;   - solution for injection - 1:200000/0.375% - active: adrenaline acid tartrate 1:200000 bupivacaine hydrochloride monohydrate 0.375%   excipient: hydrochloric acid sodium chloride sodium metabisulfite water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 1:200000;  ; bupivacaine hydrochloride monohydrate 0.5%; adrenaline acid tartrate 1:200000; bupivacaine hydrochloride monohydrate 0.5% - solution for injection - 1:200000/0.5% - active: adrenaline acid tartrate 1:200000   bupivacaine hydrochloride monohydrate 0.5% excipient: hydrochloric acid sodium chloride sodium metabisulfite water for injection active: adrenaline acid tartrate 1:200000 bupivacaine hydrochloride monohydrate 0.5% excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - marcain solutions are indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia · epidural block for surgery. · field block (minor and major nerve blocks and infiltration). analgesia · continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. · field block (minor nerve block and infiltration).

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - adrenaline acid tartrate 1:200000; bupivacaine hydrochloride monohydrate 0.75%;   - solution for injection - 1:200000/0.75% - active: adrenaline acid tartrate 1:200000 bupivacaine hydrochloride monohydrate 0.75%  

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 1:400000;  ; bupivacaine hydrochloride monohydrate 0.25%; adrenaline acid tartrate 1:400000; bupivacaine hydrochloride monohydrate 0.25% - solution for injection - 1:400000/0.25% - active: adrenaline acid tartrate 1:400000   bupivacaine hydrochloride monohydrate 0.25% excipient: hydrochloric acid sodium chloride sodium metabisulfite water for injection active: adrenaline acid tartrate 1:400000 bupivacaine hydrochloride monohydrate 0.25% excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - marcain solutions are indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia · epidural block for surgery. · field block (minor and major nerve blocks and infiltration).

Australia - English - Department of Health (Therapeutic Goods Administration)

specialites septodont pty ltd - lidocaine hydrochloride monohydrate, quantity: 20 mg/ml; adrenaline (epinephrine), quantity: 12.5 microgram/ml (equivalent: adrenaline (epinephrine) acid tartrate, qty 22.8 microgram/ml) - injection, solution - excipient ingredients: sodium chloride; potassium metabisulfite; disodium edetate; sodium hydroxide; water for injections - lignocaine solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lignocaine solutions with adrenaline are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 10 mg/ml; adrenaline (epinephrine) acid tartrate, quantity: 9.1 microgram/ml (equivalent: adrenaline (epinephrine), qty 5 microgram/ml) - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium metabisulfite; sodium hydroxide; sodium chloride - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques; infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 5 mg/ml; adrenaline (epinephrine) acid tartrate, quantity: 9.1 microgram/ml (equivalent: adrenaline (epinephrine), qty 5 microgram/ml) - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium metabisulfite; hydrochloric acid; sodium hydroxide - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 4.5 microgram/ml (equivalent: adrenaline (epinephrine), qty 2.5 microgram/ml); bupivacaine hydrochloride, quantity: 2.5 mg/ml (equivalent: bupivacaine hydrochloride monohydrate, qty 2.64 mg/ml) - injection, solution - excipient ingredients: sodium metabisulfite; hydrochloric acid; sodium hydroxide; sodium chloride; water for injections - marcain solutions are indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia; epidural block for surgery, field block (minor and major nerve blocks and infiltration). analgesia; continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. field block (minor nerve block and infiltration). the choice of 4 strengths, 0.125%, 0.25%, 0.375% and 0.5%, makes it possible to vary the degree of motor blockade.